The Utility of Focused Frailty Interventions on Patients With Advanced Heart Failure
| Status: | Completed |
|---|---|
| Conditions: | Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/14/2019 |
| Start Date: | May 4, 2018 |
| End Date: | December 31, 2018 |
A Prospective Trial to Evaluate the Utility of Focused Frailty Interventions on Patients With Advanced Heart Failure
The Researchers are doing this study to find out if the cardiac rehabilitation program can
improve measurements of frailty and improve independence, functional abilities, and feelings
about health. Frailty can be measured by weakness (as measured by hand grip strength),
slowness (as measured by walking speed), low level of physical activity, low energy or
self-reported exhaustion, and unintentional weight loss.
improve measurements of frailty and improve independence, functional abilities, and feelings
about health. Frailty can be measured by weakness (as measured by hand grip strength),
slowness (as measured by walking speed), low level of physical activity, low energy or
self-reported exhaustion, and unintentional weight loss.
Participants with advanced heart failure with a New York Heart Association class of III or IV
symptoms within the last 3 months will be identified by either their outpatient heart failure
clinic notes or inpatient cardiology notes. Patients will be approached for participation if
cardiac rehab is mentioned in the notes and inclusion/exclusion criteria it met. Once the
consent is signed, the baseline visit will be scheduled, this will be done before cardiac
rehab has started. The baseline visit include frailty assessment measured by a walk time/gait
speed test and handgrip strength test, and quality of life assessment measured using the
Kansas City Cardiomyopathy Questionnaire (KCCQ) and Minnesota Living with Heart Failure
(MLHF) questionnaire. Patients will then attend cardiac rehabilitation for six week program.
The cardiac rehab program will be designed by the individual facility due to the variation in
exercise tolerance of each patient, no universal protocol will be used. After the six weeks
of cardiac rehab, up to 16 weeks post-completion, the patient will return to Mayo Clinic
Rochester to complete the frailty and quality of life assessment.
symptoms within the last 3 months will be identified by either their outpatient heart failure
clinic notes or inpatient cardiology notes. Patients will be approached for participation if
cardiac rehab is mentioned in the notes and inclusion/exclusion criteria it met. Once the
consent is signed, the baseline visit will be scheduled, this will be done before cardiac
rehab has started. The baseline visit include frailty assessment measured by a walk time/gait
speed test and handgrip strength test, and quality of life assessment measured using the
Kansas City Cardiomyopathy Questionnaire (KCCQ) and Minnesota Living with Heart Failure
(MLHF) questionnaire. Patients will then attend cardiac rehabilitation for six week program.
The cardiac rehab program will be designed by the individual facility due to the variation in
exercise tolerance of each patient, no universal protocol will be used. After the six weeks
of cardiac rehab, up to 16 weeks post-completion, the patient will return to Mayo Clinic
Rochester to complete the frailty and quality of life assessment.
Inclusion criteria:
- Advanced heart failure patients.
- These include patients with Current NYHA class III-IV symptoms at the current time or
within the preceding three months.
- Outpatient heart failure clinic with mention of cardiac rehab in patient medical
record in the past year OR patients admitted to the hospital to any inpatient
cardiology service (including the coronary care unit (CCU)) and mention of cardiac
rehab from service.
Exclusion criteria:
- Unable to perform physical activities due to anatomic or musculoskeletal comorbidities
- Physical activity is contraindicated
We found this trial at
1
site
200 First Street SW
Rochester, Minnesota 55905
Rochester, Minnesota 55905
507-284-2511
Principal Investigator: Sudhir Kushwaha, MD
Phone: 507-422-5241
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
Click here to add this to my saved trials
